BeerCat
Landlord.
- Joined
- May 6, 2015
- Messages
- 5,292
- Reaction score
- 1,694
I fear the dump i live in will be locked down for ever. No one is dying but the infection rate is going up
Last edited by a moderator:
I believe it is a slower mutator but some believe it is getting weaker (again some scientists opinions and others think differently)I'm probably being very naive (and definitely not scientific, which pains me) but isn't there a decent chance the virus would mutate or naturally select to become less harmful over time? It's not in a virus's best interest to kill its host, so wouldn't less lethal infections tend to become more successful?
Again, give me science to contradict this by all means!
Read some stuff from Catalonia about how cases are thought he roof but hospital admissions have stayed flat.
It could be that masks, distancing and an aware population are enough to reduce the viral load enough to avoid mass hospitalizations?
Perhaps that's the correct route towards something approaching herd immunity?
Both very plausible explanations.I'm probably being very naive (and definitely not scientific, which pains me) but isn't there a decent chance the virus would mutate or naturally select to become less harmful over time? It's not in a virus's best interest to kill its host, so wouldn't less lethal infections tend to become more successful?
Again, give me science to contradict this by all means!
The really unusual thing with the COVID vaccines is that they get such huge amounts of press coverage. I remember reading that vaccine trials being stopped temporarily to investigate a potential side affect is actually incredible common, it’s just that normally no one outside the people running the trial actually know or care.Trials of a Covid-19 vaccine being developed by AstraZeneca and Oxford University will resume after it was paused due to a reported side effect in a patient in the UK.
On Tuesday, AstraZeneca said the studies were being paused while it investigated whether the reported side effect was connected with the vaccine.
But on Saturday, Oxford University said it had been deemed safe to continue.
The vaccine is seen as a strong contender among dozens being developed.
Oxford University said in a statement that it was "expected" that "some participants will become unwell" in large trials like this one.
The government's chief scientific adviser, Sir Patrick Vallance, echoed this view, telling a Downing Street press conference on Wednesday what had happened in the Oxford trial was not unusual.
The university added that the studies could now resume following the recommendations of an independent safety review committee and the UK regulator, the Medicines and Healthcare Products Regulatory Agency.
Oxford University said it would not disclose information about the patient's illness due to confidentiality reasons, but the New York Times reported that a volunteer in the UK trial had been diagnosed with transverse myelitis, an inflammatory syndrome that affects the spinal cord and can be caused by viral infections.
- UK 'must avoid party weekend' ahead of new rules
- Oxford vaccine trial paused as participant falls ill
- Oxford coronavirus vaccine triggers immune response
Hopes have been high that the vaccine might be one of the first to come on the market, following successful phase 1 and 2 testing.
Its move to Phase 3 testing in recent weeks has involved some 30,000 participants in the US as well as in the UK, Brazil and South Africa. Phase 3 trials in vaccines often involve thousands of participants and can last several years.
The World Health Organization (WHO) says nearly 180 vaccine candidates are being tested around the world but none has yet completed clinical trials.
US President Donald Trump has said he wants a vaccine available in the US before 3 November's election, but his comments have raised fears that politics may be prioritised over safety in the rush for a vaccine.
But the WHO's chief scientist has said that countries must not start "cutting corners" in the race to develop a vaccine.
"Just because we talk about speed and scale doesn't mean we start compromising or cutting corners on what would normally be assessed," Dr Soumya Swaminathan said on Wednesday.
"The process still has to follow through rules of the game. For drugs and vaccines which are given to people, you have to test their safety, first and foremost," she said.
Full article - Oxford University to resume Covid-19 vaccine trial
well someone is why not Bill?Bill Gates is behind oxidised beer.... discuss
I'm thinking the increased rates of infection with not so many serious cases may well be down to the more vulnerable keeping well out of the way and infection rates high in younger fitter people who are not being careful but who can handle it better.
The virus is not very deadly, barely more than flu, and any mutation to mutate for this reason would take a long time.I'm probably being very naive (and definitely not scientific, which pains me) but isn't there a decent chance the virus would mutate or naturally select to become less harmful over time? It's not in a virus's best interest to kill its host, so wouldn't less lethal infections tend to become more successful?
Again, give me science to contradict this by all means!
Then don't discuss sending children back to school in a Wetherspoons.Aberdeen University's Prof Pennington said last month that pubs are "far, far more dangerous places to be" when discussing sending children back to school during the pandemic.
https://www.bbc.co.uk/news/business-54144130
I've been following the discussion here for a while, haven't commented as I'm still weighing all the info. I would be interested to hear what folks make of this doctor's analysis of the situation (about 30 minutes long):
In Italy, hospitals only were under pressure in a very limited geographic area. Not really a pandemic. In places further south eg Rome total deaths actually fell, although, the thesis that epidemics develop differently in warmer and cooler regions would explain the way it is spreading in Italy.he doesn't mention anything about hospitals being overwhelmed in Italy or Spain.
That is not a non sequitur. Do masks help? The only reason we adopted them was because this disease supposedly came from China and the Chinese have been going around in masks for decades because of pollution.In many cases he says there is no evidence X helps then claims it definitely doesn't when evidence may be inconclusive, so he may not be wrong but claims non evidence to make the reverse a fact.
Sweden is looking more and more like it got its approach right and though the UK is far to different to have done the same Ireland and parts of the UK could have..
I received my test kit earlier this week and conducted it that day. It consisted of a plastic block, where you put a drop of blood in one hole and a couple of drops of solvent in another. You wait 10 minutes for a line to change colour and observe whether any of two other lines appear, indicating the presence of the shortlived IgM antibodies, ot the longer lasting IgG ones. Mine came up as negative, I had to fill in an online survey, on health, lifestyle etc. and attach a photo of the test, about 15 minutes in total.I received a letter on Friday, inviting me to take part in a Covid antibody study, run by NHS & UCL. I had a bug last christmas, which just gave me a cough for a couple of weeks, but didn't feel like a normal cold. I doubt it could have been Covid, but would be interested to find out for sure.
Enter your email address to join: